Compounded semaglutide vs Wegovy (semaglutide injection)

Pros

• +$129–$349 a month puts semaglutide within reach for people who would otherwise take nothing; branded semaglutide costs $299 a month for the Wegovy pill and $349 for the pens once past the starting doses.[1]
• +Often shipped in vials with flexible dosing, so a provider can titrate in smaller steps than the fixed branded pen doses allow.[1]

Cons

• −Not FDA approved. The agency does not review compounded drugs for safety, efficacy or manufacturing quality — potency and sterility depend entirely on the individual pharmacy.[1]
• −The FDA declared the semaglutide shortage resolved, which removed the legal basis for mass compounding of copies. Providers now rely on 'personalized dose' arguments that Novo Nordisk is actively litigating.[2]
• −Supply can stop mid-titration. A court order or state action against your compounder ends your prescription with no notice — in March 2025 Washington's Pharmacy Commission issued a limited stop-service order against Aequita, the Kirkland pharmacy that then supplied Mochi Health.[3]
• −Some products are semaglutide salts (sodium or acetate) rather than the base molecule studied in trials. The FDA has warned these are different substances.[1]

Sources

1. [1] GLP-1 Telehealth Price Report 2026
2. [2] Compounded GLP-1 providers under active litigation
3. [3] Washington Pharmacy Quality Assurance Commission: Limited Stop Service issued to Aequita Pharmacy, 13 March 2025

Pros

• +One flat $349 across every standard dose from 0.25 to 2.4 mg — no dose-escalation penalty and no refill deadline attached, unlike Lilly's conditional pricing on Zepbound.[1]
• +New patients pay $199 for the first two fills through 31 December 2026 — the first two of the four titration months.[2]
• +Approved for cardiovascular risk reduction, not only weight — the strongest insurance-coverage argument in the category.[1]
• +The longest real-world safety record of any modern weight-loss GLP-1.[1]
• +Commercially insured, the savings card can bring it to $25 a month, capped at $100 of savings per month.[2]

Cons

• −$1,349 monthly list price without insurance or the self-pay program.[1]
• −Weaker than tirzepatide where the two were tested head to head: in SURMOUNT-5, weight fell 13.7% on semaglutide against 20.2% on tirzepatide over 72 weeks.[6]
• −A month is one box of four weekly pens, so a year takes 13 boxes, not 12: $4,537 at $349 rather than the $4,188 that 'per month' implies.[1]
• −The new high dose, Wegovy HD 7.2 mg, sits outside the flat price at $399.[1]
• −Weekly injection, refrigerated storage, GI side effects during titration, and weight regain after stopping is the documented norm.[3]

Sources

1. [1] Wegovy cost and savings, NovoCare
2. [2] Wegovy Savings Offer terms, NovoCare
3. [3] GoodRx launches weight loss subscription with $199 Ozempic and Wegovy pricing
4. [4] FDA prescribing information for WEGOVY
5. [5] TrumpRx, the federal direct-purchase price site — $199 for the first two months for new self-pay patients, read 6 September 2026
6. [6] SURMOUNT-5: tirzepatide versus semaglutide in obesity (Aronne et al., N Engl J Med 2025)